NASDAQ:MTFB - MOTIF BIO PLC/S Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $8.05 -0.25 (-3.01 %) (As of 10/22/2018 04:00 PM ET)Previous Close$8.30Today's Range$7.9739 - $8.080352-Week Range$7.90 - $11.52Volume1,620 shsAverage Volume1,313 shsMarket Capitalization$123.06 millionP/E Ratio-42.37Dividend YieldN/ABeta0.09 ProfileDiscussionAnalyst RatingsChartFinancialsHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York. Receive MTFB News and Ratings via Email Sign-up to receive the latest news and ratings for MTFB and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical SymbolNASDAQ:MTFB CUSIPN/A Webwww.motifbio.com Phone212-210-6248 Debt Debt-to-Equity Ratio-4.25 Current Ratio1.31 Quick RatioN/A Price-To-Earnings Trailing P/E Ratio-42.37 Forward P/E Ratio-5.00 P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book Value($0.68) per share Price / Book-11.84 Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees8 Outstanding Shares14,830,000Market Cap$123.06 million MOTIF BIO PLC/S (NASDAQ:MTFB) Frequently Asked Questions What is MOTIF BIO PLC/S's stock symbol? MOTIF BIO PLC/S trades on the NASDAQ under the ticker symbol "MTFB." What price target have analysts set for MTFB? 5 brokerages have issued twelve-month price objectives for MOTIF BIO PLC/S's stock. Their forecasts range from $7.00 to $32.00. On average, they anticipate MOTIF BIO PLC/S's share price to reach $19.50 in the next year. This suggests a possible upside of 142.2% from the stock's current price. View Analyst Price Targets for MOTIF BIO PLC/S. What is the consensus analysts' recommendation for MOTIF BIO PLC/S? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MOTIF BIO PLC/S in the last year. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MOTIF BIO PLC/S. What are Wall Street analysts saying about MOTIF BIO PLC/S stock? Here are some recent quotes from research analysts about MOTIF BIO PLC/S stock: 1. HC Wainwright analysts commented, "Valuation methodology, risks and uncertainties. We employ a risk- adjusted net present value (rNPV) approach that yields $600M for iclaprim—with a 90% probability of success, 16% discount rate and 40% effective tax rate—and a price per share of $32.00 based on about 19M American Depositary Shares (ADSs) outstanding as of mid-2019." (8/14/2018) 2. WBB Securities analysts commented, "We believe there is a critical need for novel antibiotics. Based on the clinical data provided through Phase 3 studies REVIVE-1 and REVIVE-2, iclaprim has a high probability of obtaining FDA approval. However, success for MTFB is not just manifest through clinical proof, but also through negotiating the vagaries of reimbursement, gaining clinician acceptance, hospital inclusion and inclusion in the overall patient care paradigm. Additionally, we remain concerned about the resourcing path regarding the future of iclaprim. We are therefore initiating our coverage of MTFB with a Sell rating and a 12- month price target of $7.00." (12/29/2017) Who are some of MOTIF BIO PLC/S's key competitors? Some companies that are related to MOTIF BIO PLC/S include Akebia Therapeutics (AKBA), Kezar Life Sciences (KZR), Adamas Pharmaceuticals (ADMS), Stemline Therapeutics (STML), Progenics Pharmaceuticals (PGNX), Aurinia Pharmaceuticals (AUPH), ArQule (ARQL), OptiNose (OPTN), Depomed (DEPO), BioSpecifics Technologies (BSTC), Corium International (CORI), Forty Seven (FTSV), Abeona Therapeutics (ABEO), Beyondspring (BYSI) and TG Therapeutics (TGTX). Who are MOTIF BIO PLC/S's key executives? MOTIF BIO PLC/S's management team includes the folowing people: Mr. Graham George Lumsden, CEO & Exec. Director (Age 58)Mr. Jonathan E. Gold, CFO & Exec. Director (Age 45)Dr. David B. Huang, Chief Medical Officer (Age 43)Mr. Robert Dickey IV, Advisor (Age 62)Liam O'Donoghue, Company Sec. When did MOTIF BIO PLC/S IPO? (MTFB) raised $17 million in an initial public offering (IPO) on Friday, November 18th 2016. The company issued 2,400,000 shares at a price of $6.98 per share. H.C. Wainwright & Co. served as the underwriter for the IPO. How do I buy shares of MOTIF BIO PLC/S? Shares of MTFB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is MOTIF BIO PLC/S's stock price today? One share of MTFB stock can currently be purchased for approximately $8.05. How big of a company is MOTIF BIO PLC/S? MOTIF BIO PLC/S has a market capitalization of $123.06 million. The company earns $-44,810,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. MOTIF BIO PLC/S employs 8 workers across the globe. What is MOTIF BIO PLC/S's official website? The official website for MOTIF BIO PLC/S is http://www.motifbio.com. How can I contact MOTIF BIO PLC/S? MOTIF BIO PLC/S's mailing address is 125 Park Avenue 25th Floor, New York NY, 10011. The company can be reached via phone at 212-210-6248 or via email at [email protected] MarketBeat Community Rating for MOTIF BIO PLC/S (NASDAQ MTFB)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 120 (Vote Outperform)Underperform Votes: 122 (Vote Underperform)Total Votes: 242MarketBeat's community ratings are surveys of what our community members think about MOTIF BIO PLC/S and other stocks. Vote "Outperform" if you believe MTFB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTFB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/22/2018 by MarketBeat.com StaffFeatured Article: What does the Dow Jones Industrial Average (DJIA) measure?